New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 3, 2013
19:02 EDTCYTKCytokinetics initiated with an Overweight at Piper Jaffray
Target $4.
News For CYTK From The Last 14 Days
Check below for free stories on CYTK the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
April 23, 2014
09:13 EDTCYTKCytokinetics should be owned ahead of data, says Roth Capital
Roth Capital recommends that investors own Cytokinetics ahead of data expected to be unveiled on April 29. The firm thinks the data could be "a transformational event" for the company, and reiterates a $25 price target and Buy rating on the shares.
April 21, 2014
10:58 EDTCYTKCytokinetics mentioned positively at Piper Jaffray
Subscribe for More Information
April 16, 2014
14:33 EDTCYTKCytokinetics volatility elevated into trial data announcement
Cytokinetics May call option implied volatility is at 279, August is at 180, November is at 140; compared to its 26-week average of 158 according to Track Data, suggesting larger near term price movement into the tirasemtiv Phase IIb trial data likely to be announced at the American Academy of Neurology meeting in late April.
April 11, 2014
10:56 EDTCYTKOptions with increasing implied volatility: CYTK VJET DATA GRPN CTRP
April 10, 2014
11:23 EDTCYTKOptions with increasing implied volatility: CYTK BX
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use